Pyszczymuka Greg insider trades
Pyszczymuka Greg has filed 18 Form 4s with the SEC that we hold, for Aytu Biopharma, INC (AYTU) (Chief Commercial Officer) and EVOK (Director). Across all of them we count 2 purchases worth $46.4K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 100,000 shares of Aytu Biopharma, INC worth $24.0K, dated 2022-12-19. The first filing on our record is dated 2022-12-21 and the latest 2026-07-30.
Aytu Biopharma, INC (AYTU)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-19 | P, purchase reported on Form 4 | 100,000 | $24.0K | 2022-12-21 |
| 2023-06-16 | P, purchase reported on Form 4 | 12,000 | $22.4K | 2023-06-20 |
EVOK
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1952920) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms